Experion Holdings Ltd. (to be closed)

lockPrivate Group

Please join the new Experion Group on 8020 Connect. https://www.8020connect.com/groups/experion-holdings-ltd

people29 Members       (0)

Corporate Profile
Group Admins:
  • Thumb 8020 monitor 200200 2
  • Thumb 20190424 083700 film4 1
Request Membership


Experion Holdings Ltd. (to be closed)

lockPrivateGroup

Please join the new Experion Group on 8020 Connect. https://www.8020connect.com/groups/experion-holdings-ltd ...

people29 Members       (0)

Judy-Ann Pottinger posted an update EXPERION - IMPORTANT GROUP NOTICE WE ARE MOVING PLEASE COME WITH US in EXPERION HOLDINGS LTD. (TO BE CLOSED)

In order for Experion Holdings Ltd, to fully move our brand from our old name Viridium Pacific to Experion Holdings, disclosed in our new release dated June 10th, 2019, we asked 8020 to launch a new group. Our 8020 group had a URL with the Viridium name displayed, and as such we asked that the group be changed to the display URL using our new Experion Holdings name.


Please join the new group by clicking the link, before the old group is deleted from the 8020 site. http://connects.company/ExperionEXP


Thank you


Judy-Ann Pottinger


IR Manager, Experion Holdings Ltd.


 

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Experion Holdings Ltd. Trading on Frankfurt Stock Exchange Under New Company Name in EXPERION HOLDINGS LTD. (TO BE CLOSED)

VANCOUVER, BC / ACCESSWIRE / July 3, 2019 / Experion Holdings Ltd. ("Experion" or the "Company") (TSXV: EXP) (OTCQB:EXPFF) (FRANKFURT:MB31), formerly Viridium Pacific Group Ltd., announced today that its shares are now trading on the Frankfurt Stock Exchange under the Company's new name Experion Holdings Ltd. The symbol and WKN have not changed and remains ''MB31" and ''WKN:A2PLZG".


The Company's shares continue to be listed on the TSXV under the ticker ''EXP" and on the OTCQB market in the US under the ticker "EXPFF"


Mr. Jay Garnett, Chief Executive Officer commented, "Experion is pursuing international growth strategies, such as the vast export market in countries with early opportunities. Having our new name reflected on the Frankfurt Stock Exchange will allow us to grow our shareholder base throughout Europe and attract global recognition as we work diligently to unlock value for our current shareholders and new shareholders to come"


The Frankfurt Stock Exchange is one of the world's largest trading centres for securities. With a share in turnover of around 90 per cent, it is the largest of Germany's seven stock exchanges and it is an international trading centre, which is reflected in the structure of its participants. Of the approximately 200 market participants, roughly 50% are from countries other than Germany.


On June 25th Experion announced an LOI with a Polish Import and Distribution Company. The LOI will see Experion exporting medical flower products to Poland for scientific purposes enabling the Polish Company to test and develop Experion's flower products. Ultimately Experion's goal is to export increased quantities of its flower products into Poland for medical use.


Mr. Jay Garnett further commented "As investor interest and momentum in the cannabis industry continues to accelerate, Experion will be well-positioned to participate in the European and global cannabis markets as they continue to expand, and we receive our EU GMP certification that will allow Experion products to be exported across Europe."


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's website www.experionwellness.com or contact:


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com


We invite all investors and other interested parties to join the Experion Holdings portal on 8020 Connect. Join here: http://connects.company/Experion


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Experion Holdings Ltd.


View source version on accesswire.com:
https://www.accesswire.com/550713/Experion-Holdings-Ltd-Trading-on-Frankfurt-Stock-Exchange-Under-New-Company-Name

!
Thumb 8020 monitor 200200 2

8020Admin

15 days

8020Admin posted a press release Experion Announces Letter of Intent with Polish Import and Distribution Company in EXPERION HOLDINGS LTD. (TO BE CLOSED)

VANCOUVER, BC / ACCESSWIRE / June 25, 2019 / Experion Holdings Ltd. ("Experion" or the "Company") (TSXV: EXP) (OTCQB:EXPFF) (FRANKFURT:MB31), formerly Viridium Pacific Group Ltd., is pleased to announce that it has signed a non-binding Letter of Intent (''LOI'') with a Polish Import and distribution Company (''Polish Company'') to export medical flower products to Poland for scientific purposes.


The executed LOI consist of two parts, part one, will see Experion exporting medical flower products to Poland for scientific purposes enabling the Polish Company to test and develop Experion's flower products. Upon the successful testing and development of the flower products and once a viable export and import channel has been established between Canada and Poland, part two of the LOI will commence which will see Experion exporting increased quantities of its flower products into Poland for medical use. Experion will also have completed its EU GMP certification which will allow for part two of the LOI.


Mr. Jay Garnett, Chief Executive Officer commented, "The LOI represents a major milestone for Experion. As medical marijuana becomes more legalized around the world, Experion continues to focus on the vast export market in countries with early opportunities. By exporting products for scientific research, we are able to move past barriers to entry and be one of the first Canadian producers to enter Poland"


Pursuant to the LOI, Experion and the Polish Import Company will work towards a definitive agreement as Experion seeks to increase export opportunities in Europe and continue to build Experion's international distribution chain.


Mr. Jay Garnett further commented "I am truly proud of the work that the team has done and the great strides we have made to date. This is yet another result of solid teamwork that can only be achieved by having a shared vision and goal as we work diligently to unlock value for our most important asset and audience - our shareholders.


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's website www.experionwellness.com or contact:


Experion Holdings Ltd


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com


We invite all investors and other interested parties to join the Experion Holdings portal on 8020 Connect. Join here: http://connects.company/Experion


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Experion Holdings Ltd.


View source version on accesswire.com:
https://www.accesswire.com/549774/Experion-Announces-Letter-of-Intent-with-Polish-Import-and-Distribution-Company

!
Thumb 8020 monitor 200200 2

8020Admin

19 days

8020Admin posted a press release Experion's Brand, Kanabé Goods Co., Well Positioned to Take Advantage of New Health Canada Regulations in EXPERION HOLDINGS LTD. (TO BE CLOSED)


VANCOUVER, BC / ACCESSWIRE / June 21, 2019 / Experion Holdings Ltd. ("Experion" or the "Company") (TSXV: EXP) (OTCQB:EXPFF), formerly Viridium Pacific Group Ltd., is pleased to provide an update on the Company's brands positioned to take advantage of Health Canada's final regulations for Value-Add Products (VAP's) such as cannabis topicals, edibles and extracts as well as Health Canada's proposal to create a new category ''Cannabis Health Products'' for therapeutic treatment of minor ailments like sleeplessness or sore muscles or for use in pets, paving the way for large new untapped market.


Mr. Jay Garnett, Chief Executive Officer commented "Experion is in continued development of our wellness-centric brand Kanabé Goods Co. www.kanabe.ca for the launch of value-add products (VAP's). There are currently 50 plus existing formulations which we have the ability to produce in our facility and we are also working with key strategic partners for large scale commercial roll-out. These health and wellness products such as non-intoxicating topicals and micro-dosed oils are an entry point for new consumers, broadening the market potential. The Experion management team has decades of experience in consumer-packaged goods and is well positioned to be a first mover in this category which in turn will enable Experion to stand firm in our commitment of unlocking value for our shareholders"


The VAP's regulations come into force October 17, 2019 with product availability earliest December 16th, 2019. Furthermore, Health Canada's proposal for Cannabis Health Products opens the door for a bigger opportunity. The proposal looks to treat health and wellness products with cannabis, similar to Natural Health Products which allows the product to make health claims based on evidence but without the oversight of a practitioner.


Mr. Garnett further commented "A Kanabé topical balm that is non-intoxicating, for example, could potentially be sold via pharmacies or online without the restrictions to have a medical cannabis prescription or buy through a licensed cannabis retailer. The accessibility to purchase is much easier on the consumer, as well as the use of the product much clearer." This proposal further aligns to our educational and public outreach efforts from our Cannabis Wellness Expert and Co-Founder of Kanabé, Krystal Laferriere, who had created the product line to soothe side-effects and other ailments suffered as a result of her Crohn's Disease."


Health Canada is asking the public to submit feedback on this new category via consultation paper until September 3rd.


https://www.canada.ca/en/health-canada/programs/consultation-potential-market-cannabis.html


Health Canada Final Regulations for Value-Add Products


https://www.canada.ca/en/health-canada/news/2019/06/health-canada-finalizes-regulations-for-the-production-and-sale-of-edible-cannabis-cannabis-extracts-and-cannabis-topicals.html


About Kanabe Goods Co


Kanabé Goods Co. www.kanabe.ca creates therapeutic health and wellness products containing cannabis and has over 50 formulations in its portfolio including topical salves, lotions, oils as well as edible oils and capsules. Kanabé products were developed to target and soothe various aliments by combining cannabinoids, terpenes and aromatherapy with a focus on discretion and ease of use by developing products that are already found in consumers everyday life. Kanabé is an adult-use, over-the-counter health & wellness brand ingraining into daily actions and rituals for comfort and solutions to acute problems ranging from sore muscles, to sleep and skin issues.


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's website www.experionwellness.com or contact:


Experion Holdings Ltd
Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com


We invite all investors and other interested parties to join the Experion Holdings portal on 8020 Connect. Join here: http://connects.company/Experion


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Experion Holdings Ltd


View source version on accesswire.com:
https://www.accesswire.com/549436/Experions-Brand-Kanab-Goods-Co-Well-Positioned-to-Take-Advantage-of-New-Health-Canada-Regulations

!

Experion begins trading on OTCQB Venture Market – The Case for Experion – MY TAKE

Members, I hope you saw the news issued yesterday that Experion is now trading on the OTCQB in complement, to our TSX V listing, this is great for EXP for several reasons. The most important is the fact is that we now have a direct presence among American retail and institutional investors, which will, in turn, allow quotation access to USA investment advisors. This new access opens the door to USA investment that was not easily accessible before when trading solely on a Canadian trading platform. American registered retail advisors, who don't have direct quotation access to Canadian issuers, are reluctant to look at the possibility of investment for their clientele, as they cannot get an instant quotation, and direct trading. Now with our new listing on the OTCQB, this will provide all American retail and institutional advisors real-time quotes and a trading platform in the USA.

!

Experion begins trading on OTCQB Venture Market – The Case for Experion – MY TAKE

Members, I hope you saw the news issued yesterday that Experion is now trading on the OTCQB in complement, to our TSX V listing, this is great for EXP for several reasons. The most important is the fact is that we now have a direct presence among American retail and institutional investors, which will, in turn, allow quotation access to USA investment advisors. This new access opens the door to USA investment that was not easily accessible before when trading solely on a Canadian trading platform. American registered retail advisors, who don't have direct quotation access to Canadian issuers, are reluctant to look at the possibility of investment for their clientele, as they cannot get an instant quotation, and direct trading. Now with our new listing on the OTCQB, this will provide all American retail and institutional advisors real-time quotes and a trading platform in the USA.

!
Thumb 8020 monitor 200200 2

8020Admin

21 days

8020Admin posted a press release Experion Holdings Ltd Announces Its U.S. Listing on OTCQB Under the Symbol EXPFF in EXPERION HOLDINGS LTD. (TO BE CLOSED)

VANCOUVER, BC / ACCESSWIRE / June 19, 2019 / Experion Holdings Ltd. ("Experion" or the  "Company") (TSX-V: EXP) (OTCQB: EXPFF), formerly Viridium Pacific Group Ltd., today announced it has qualified to trade on the OTCQB Venture Market. Experion also has the intention to seek The Depositary Trust Company ("DTC") eligibility.


The common shares of Experion will begin trading on the OTCQB, effective immediately, under the ticker symbol "EXPFF." U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.


Mr. Jay Garnett, Chief Executive Officer, commented "We are proud to qualify for a listing on the OTCQB marketplace.  This is an important step and milestone for the Company as it aims to increase its presence among American retail and institutional investors. This move will provide investors with additional liquidity and increased trading capacity and reaffirms to the markets that we are indeed committed to unlocking value for our shareholders".


Experion will continue to trade on the TSX Venture Exchange under its existing symbol "EXP".


About OTCQB Venture


The OTCQB Venture is the premier marketplace for entrepreneurial and development stage U.S. and international companies that are committed to providing a high-quality trading and information experience for their US investors. To be eligible, companies must be current in their financial reporting, pass a minimum bid price test, and undergo an annual company verification and management certification process. The OTCQB Venture quality standards provide a strong baseline of transparency, as well as the technology and regulation to improve the information and trading experience for investors.


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB. 


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


Experion Holdings Ltd 


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com 


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Experion Holdings Ltd.



View source version on accesswire.com:
https://www.accesswire.com/549207/Experion-Holdings-Ltd-Announces-Its-US-Listing-on-OTCQB-Under-the-Symbol-EXPFF

!

Good morning Experion members, a great article to share with you as it is very germane to the work Experion has done and is continuing to do. Experion is working to get ready for value-add products legislation through its brand, Kanabe Goods Co. which formulates topicals and micro-dosed oils targeted at the wellness and therapeutic market.

https://www.cbc.ca/news/politics/marijuana-cannabis-edibles-extracts-vaping-1.5174844?fbclid=IwAR1rllpsYIkmQy309cMGQRumgRPYRwTUpsNn97y9avch0sUMPXTJmYJrt1Y

!
Thumb 8020 monitor 200200 2

8020Admin

23 days

8020Admin posted a press release Experion Announces Resignation of Board Member in EXPERION HOLDINGS LTD. (TO BE CLOSED)

VANCOUVER, BRITISH COLUMBIA / ACCESSWIRE / June 17, 2019 / Experion Holdings Ltd. ("Experion" or the "Company") (TSXV: EXP), formerly Viridium Pacific Group Ltd., wishes to announce that Michael Kohut has resigned from the board of directors of Experion effectively immediately.


Mr. Jay Garnett, Chief Executive Officer, commented, "We would like to thank Mike for his efforts and contributions. We are in the process of evaluating candidates that will strengthen our board and support management in unlocking value for all shareholders."


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


Experion Holdings Ltd


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com


SOURCE: Experion Holdings Ltd.


View source version on accesswire.com:
https://www.accesswire.com/548952/Experion-Announces-Resignation-of-Board-Member

!
Thumb 8020 monitor 200200 2

8020Admin

29 days

8020Admin posted a press release Experion Adds Veteran Financial and Business Magnate to Board of Directors with the Appointment of William (Bill) Kenneth Dickie in EXPERION HOLDINGS LTD. (TO BE CLOSED)

VANCOUVER, BC / ACCESSWIRE / June 11, 2019 / Experion Holdings Ltd. ("Experion" or the "Company") (TSX-V: EXP), formerly Viridium Pacific Group Ltd., is pleased to announce the appointment of a new member to its Board of Directors. Mr. William (Bill) Kenneth Dickie will join Mr. Jay Garnett, Chief Executive Officer of Experion Holdings Ltd, on the Board of Directors effective June 11, 2019.


Mr. Dickie brings substantial financial oversight and business advisory experience to Experion's Board. Mr. Dickie is currently, the Co‐Chief Investment Officer and a Portfolio Manager at Matco Financial, a Calgary, Alberta based independent discretionary investment counsellor and asset management firm. Mr. Dickie has over thirty-five (35) years of experience in the financial and investment industry, and is responsible for the investment operations and strategic development of Matco Financial Inc. He is a member of the Investment Committee, Asset Mix Committee and Chair of the Equity Working Group. As the Co-Chief Investment Officer of Matco Financial Inc., he has oversight of the Matco Investment Platform.


Mr. Dickie has been helping private clients achieve their goals since 1979, starting his career with McLeod Young Weir Ltd. Prior to co-founding Matco Financial Inc. in 2006, Mr. Dickie was President and Director of Fiduciary Trust Company of Canada, formerly part of Bissett Investment Management. where he established a new business strategy and model. Mr. Dickie graduated from the University of Alberta having earned a Bachelor of Commerce and holds the Chartered Financial Analyst designation.


"Bill brings a wealth of financial and governance expertise" said Jay Garnett, CEO of Experion Holding Ltd. "his appointment furthers our commitment to a strong and relevant board. Bill's addition to the Board is significant as he brings deep knowledge of the cannabis industry through his role as Co-Chief Investment Officer and one of the Lead Portfolio Managers of the Matco's Cannabis Fund; as well as extensive financial and deal-making skills. His firsthand approach to mentoring and building new companies in fast growing industries will be invaluable to Experion. We look forward to Bill's guidance as we continue to execute on our strategic objectives for 2019 to unlock value and grow Experion's market valuation."


Mr. Dickie was an early investor in EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, Alberta, which Experion acquired in February 2019.


Mr. Dickie commented, "I am pleased to be joining the Board of Experion at this important inflection point in the Company's history within an exciting and dynamic market environment. As Experion embarks on a period of tremendous growth and differentiation, I look forward to working with Jay and the management team".


Resignation of Sean McNeil


Mr. Sean MacNeil has recently resigned from his position as a Director on Experion's Board of Directors to focus on other matters. Mr. Jay Garnett added, "We wish to sincerely thank Sean for his important contributions as a key contributor in the Company's evolution and growth over the last several years. We wish him well in his future endeavors."


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


Experion Holdings Ltd


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Experion Holdings Ltd


View source version on accesswire.com:
https://www.accesswire.com/548360/Experion-Adds-Veteran-Financial-and-Business-Magnate-to-Board-of-Directors-with-the-Appointment-of-William-Bill-Kenneth-Dickie

!
Thumb 8020 monitor 200200 2

8020Admin

30 days

8020Admin posted a press release Viridium Pacific Group Ltd. Announces Name Change to Experion Holdings Ltd. in EXPERION HOLDINGS LTD. (TO BE CLOSED)

VANCOUVER, BC / ACCESSWIRE / June 10, 2019 / Viridium Pacific Group Ltd. (the ''Company") (TSX-V: VIR ) is pleased to announce that the Company has changed its name from "Viridium Pacific Group Ltd." to "Experion Holdings Ltd." (TSX-V: EXP).The Company's shareholders approved the name change at a special meeting of shareholders held on May 31, 2019. Effective on market opening on June 10, 2019, the common shares of the Company will commence trading on the TSX Venture Exchange under the Company's new name, Experion Holdings Ltd., and under the trading symbol ''EXP". With the new change in name, there is no consolidation of capital and the CUSIP Number will be 30219B109.


Mr. Jay Garnett, Chief Executive Officer, commented, "We are excited to have both our Licence and corporate entity under Experion. Having a focused brand strategy, under one corporate brand, will bring alignment to the market and our shareholders. In addition, it will allow us to better communicate our value proposition as we work to unlock value and communicate our accomplishments to the market and stakeholders."


No action is required to be taken by current shareholders in connection with the change in name and no change has been made to Experion Holdings Ltd. share capital.


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


A new Company website will be rolled out in the following weeks, for now please visit www.viridiumpacific.com or contact our Investor Relations Consultant (details below) for further information.


Experion Holdings Ltd


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Viridium Pacific Group Ltd.




View source version on accesswire.com:
https://www.accesswire.com/548214/Viridium-Pacific-Group-Ltd-Announces-Name-Change-to-Experion-Holdings-Ltd

!
Thumb 8020 monitor 200200 2

8020Admin

1 month

8020Admin posted a press release Experion Biotechnologies Inc's Krystal Laferriere Sits on Panel at Lift & Co Expo Consumer Weekend in EXPERION HOLDINGS LTD. (TO BE CLOSED)


VANCOUVER, BRITISH COLUMBIA / ACCESSWIRE / June 8, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (US OTC; VIRFF) the parent company of Experion Biotechnologies Inc. ("Experion"), a Health Canada licensed cultivator and processor of Cannabis is pleased to announce that the Company will take part in a panel discussion at the Lift & Co. Expo Consumer Weekend on June 9th in Toronto.


Krystal Laferriere, Marketing Manager Experion Wellness, will sit on a panel with industry heavyweights such as Dr. Ira Price, Assistant Clinical Professor Emergency Medicine at McMaster University, and NextLeaf Solutions CEO, Paul Pedersen. The panel discussion will take place at the Expo Consumer Weekend on Sunday June 9th at 2:20pm to 3:00pm EST on Cannabis, Clarity & Wellness - New and Overdue Treatments and Therapies.


CEO Jay Garnett commented "We are excited to have Krystal be a key contributor and presenter at the upcoming Lift & Co Expo. Krystal is Experion's ambassador, a trusted and resonant voice in the medical Cannabis space. Krystal has fostered a large following on social media primarily because of her personal struggles with Crohn's disease and her ultimate discovery of cannabis as a therapy. Having Krystal as Experion's Cannabis Wellness Expert spearheading cannabis education, marketing and brand ambassadorship, enables Experion to have an authentic voice as we position Experion to be a dominant producer of a wide spectrum of cannabis products in the near future."


We invite all attendess of the Lift & Co Expo to join us on Sunday, June 9th at 2:20 pm to 3:00 pm.


CEO Jay Garnett further commented "We are excited about the many ways our products can enhance wellness, helping people sleep better and alleviating a range of chronic conditions. We are proud of our progress in the pain management field, particularly with our two-piece pill. It is the only cannabis product in Canada to have reached stage three clinical trials for post-operative pain relief."


Lift & Co. (TSXV: LIFT) is a cannabis-focused technology and media company that monetizes a platform of advertising solutions, events, and data insights to enable cannabis businesses to better understand, target and ultimately monetize cannabis consumers. Lift & Co. operates a leading product-comparison resource of federally regulated cannabis products; provides customized marketing solutions and data-backed insights into consumer and product trends; and connects businesses and consumers through its digital platform, and at its leading events, the Retail Tradeshows, the Lift & Co. Expos and the Canadian Cannabis Awards. The Lift & Co. Cannabis Retail Training Certification, developed in an exclusive partnership with MADD Canada, is available to both government and private clients. Learn more at lift.co.


Viridium Pacific Group Ltd. and its wholly owned subsidiary, Experion Biotechnologies Inc., together with one of its directors and several other named defendants were named in a civil claim filed by an ex-CEO of Viridium, Stephen Serenas. Mr. Serenas is seeking damages among other remedies, for breach of contract and wrongful dismissal for his employment as CEO of Viridium in the form of 10,270,437 shares of Viridium, or, alternatively, $5,546,035 as cash in lieu of the shares; in addition to 149,625 restricted stock units fully vested in Viridium. Management considers this claim to be without merit and both Viridium and Experion intend to vigorously defend the action.


About Viridium


Viridium Pacific Group Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX labs, a medical products production and clinical research company based in Calgary, AB.


Viridium is invested in a portfolio of products including to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's www.viridiumpacific.com or contact:


Viridium Pacific Group Ltd.


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com
www.viridiumpacific.com


We invite all investors and other interested parties to join the Viridium portal on 8020 Connect. Join here: http://connects.digital/Viridium8.


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Viridium Pacific Group Ltd.


View source version on accesswire.com:
https://www.accesswire.com/548151/Experion-Biotechnologies-Incs-Krystal-Laferriere-Sits-on-Panel-at-Lift-Co-Expo-Consumer-Weekend

!
Thumb 8020 monitor 200200 2

8020Admin

1 month

8020Admin posted a press release Viridium Pacific Group Announces Results Of Annual General Meeting in EXPERION HOLDINGS LTD. (TO BE CLOSED)


VANCOUVER, BC / ACCESSWIRE / June 6, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (US OTC; VIRFF) is pleased to announce the results of its annual general and special meeting of shareholders held on May 31, 2019 (the "Meeting").


The Company put forward the following resolutions to be voted on by shareholders at the Meeting, all of which were approved:


(i) Appointment of MNP LLP, Chartered Professional Accountants as Auditors of the Company for the ensuing year and authorizing the Directors to fix their remuneration.


(ii) Fixing the number of directors of the Company at seven (7);


(iii) The election of directors - 01. Michael Black 02. Joel Dumaresq 03. Deni Echino 04. Jay Garnett 05. Michael Kohut 06. Sean MacNeil 07. Harry McWatters


(iv) Approve a special resolution to change the name of the Corporation to Experion Holdings Ltd.


(v) Approval of the Corporation's stock option plan


Each of the directors elected at the meeting being, Michael Black, Joel Dumaresq, Deni Echino, Jay Garnett, Michael Kohut, Sean MacNeil and Harry McWatters will hold office until the next annual meeting of the Company or until their earlier resignation or removal. Mr. Harry McWatters accepted the role of Chairman for the ensuing year, Mr. Joel Dumaresq was appointed the Audit Chair and Mr. Michael Black was appointed the Compensation and Nominations Chair.


In addition, the Company granted 156,250 Restricted Stock Units ("RSUs") to its directors and a former director, of which 25,000 RSUs will vest on May 31, 2020 and the remaining 131,250 RSUs will vest 12 months after the directors resign.


CEO Jay Garnett commented. "We are pleased to have our board elected with high acceptance of our voting shareholders. Having a strong Board is fundamental to Experion as we move forward with our strategy to unlock value and grow Experion's valuation in the marketplace. Our focused mandate to unlock value in our licenses, in our team and in our strategy gives Experion a sound footing in building a progressive cannabis company regionally, nationally and internationally."


About Viridium


Viridium Pacific Group Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX labs, a medical products production and clinical research company based in Calgary, AB.


Viridium is invested in a portfolio of products including to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's www.viridiumpacific.com or contact


Viridium Pacific Group Ltd.
Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com
www.viridiumpacific.com


We invite all investors and other interested parties to join the Viridium portal on 8020 Connect. Join here: http://connects.digital/Viridium8


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Viridium Pacific Group Ltd.


View source version on accesswire.com:
https://www.accesswire.com/547926/Viridium-Pacific-Group-Announces-Results-Of-Annual-General-Meeting

!

Good morning
Please check out this article from Green Chips
Jeff Siegel of Green Chip Stocks known for his skill in picking winning Cannabis stocks says BUY Viridium Pacific (TSX-V:VIR)


insert_drive_fileEXPERION_QA_-Green_Chip_Stocks_FINAL_052719.pdf
Thumb experion qa  green chip stocks final 052719

!

Judy-Ann Pottinger posted an update German medical cannabis market led by older patients; 750 kilograms of flower imported in Q1 in EXPERION HOLDINGS LTD. (TO BE CLOSED)

Dear Investor,


I would like to share an article, excerpt and link below, that speaks to the German medical cannabis market.  The German marketplace described as a ‘’linchpin for many international marijuana companies’’ is an important one for Viridium and in fact, Viridium has already secured entry into the German medical cannabis market.


More than 750 kilograms of medical cannabis flower was imported to Germany in the first quarter of this year, putting the country on pace to import about the same amount in 2019 as it did last year – 3,000 kilograms.


This is according to new data from the government, providing clarity on the actual size of a market that is a linchpin for many international marijuana companies.


https://mjbizdaily.com/german-medical-cannabis-market-led-by-older-patients-750-kg-flower-imported-q1/


Viridium announced on December 27, 2018, that the Company had signed an agreement with INOPHA GmbH a pharmaceutical distributor for the German market to enter the tender process within Germany and acquire a license to cultivate medical cannabis – the link below.


Chief Executive Officer, Jay Garnett, commented: “The German medical cannabis patient relies on high-quality cannabis supply that meets the rigorous standards of regulations, such as those governing our industry in Canada. INOPHA’s interest in working with a Canadian LP, such as Viridium, stems from the need to partner with a proven operator with a track record of supplying the medical market.” Mr. Garnett further stated, “We look forward to working with INOPHA to build a quality medical cannabis producer in Germany.”


https://www.viridiumpacific.com/viridium-signs-agreement-with-german-partner-inopha-entering-the-tender-process-to-cultivate-medical-cannabis-in-germany/


Viridium continues to execute on its business plan, a key and seminal move by Viridium has been to secure the requisite licenses and seek out partnerships that will greatly enhance the Company’s growth domestically and internationally.


Thank you for reading.  Stay Tuned!!!!

!
Thumb b7c819c2f8949d2a4df7a13fade3f5a1 bpfull

DArcy Funfer replied to the press release Judy-Ann Pottinger  update in EXPERION HOLDINGS LTD. (TO BE CLOSED)

2 months

2 months

DArcy Funfer posted a press release IN CASE YOU MISSED IT in EXPERION HOLDINGS LTD. (TO BE CLOSED)

Dear Investor  


IN CASE YOU MISSED IT


In a press release on Monday, May 13th – Viridium announced that the company had joined the 8020 Connect Investor Community and announced the Company’s AGM to be held on Friday, May 31, 2019


THE AGM


One of the matters to be considered at the AGM will be the election of Directors, each director of the Corporation is elected annually and holds office until the next AGM.  We have three new Directors being considered at the upcoming AGM – Michael Black, Michael Kohut, and Joel Dumaresq.  Having received several questions and request for additional information on these three new directors, we are providing a more detailed Bio for each of Michael Black, Michael Kohut, and Joel Dumaresq. 



Michael J. Black is the senior energy Partner in Fasken’s Calgary office. With significant experience leading large and complex M&A transactions, including several multi-billion-dollar M&A deals, Mr. Black is counsel to numerous domestic and international energy companies. Both clients and peers recognize him as a leading, results-oriented advisor.  Mr. Black has worked exclusively in the energy field, both in private practice and as in-house counsel, with a comprehensive focus on the upstream, midstream and the service sectors of the oil and gas business.  Mr. Black also negotiates and drafts a wide variety of domestic and international energy agreements, including joint operating, acquisition, joint venture, product marketing, and transportation, as well as farm-outs and production sharing contracts.  Having negotiated and closed transactions in over 20 countries, Mr. Black is an expert in providing legal and commercial advice in numerous jurisdictions. He was also the General Counsel of the state-owned oil and gas corporation in the State of Qatar. This combined with his extensive hands-on experience, both in private practice and as in-house counsel, allows him to be fully aligned with clients’ business objectives.


Mr. Black is a graduate of the Institute of Corporate Directors in Canada. Michael has been on the board of eight different companies, including roles as both Chairman of the Board and the Chairman of various committees. He is currently a director of two publicly traded companies.



Mr. Michael G. Kohut serves as the Senior Vice President and Chief Financial Officer at Canadian International Oil Corp. since February 2019. Mr. Kohut has been Chairman of Briko Energy Corp since April 11, 2019. Mr. Kohut was the President and Chief Executive Officer of Briko Energy Corp until April 11, 2019. He has been Chairman of the Board at Big Rock Brewery Inc. since November 9, 2017. He was the Vice President of Finance at Paramount Resources Ltd. from November 23, 2017, to April 2018. Mr. Kohut was the Chief Financial Officer of Paramount Resources (Trilogy Energy Corp) Ltd. since June 1, 2006, to October 2017. Mr. Kohut has over 15 years’ experience in financial management. Mr. Kohut served as President of Chinook Tyee Industry Limited (formerly, Global Railway Industries Ltd.) from January 1997 to October 3, 2005, and Chief Executive Officer until October 3, 2005. He served as Senior Tax Manager of KPMG in Calgary. He has been a Director of Big Rock Brewery Inc. since March 7, 2008, and Panterra Resource Corp. since May 22, 2014. He serves as an Independent Director at West Valley Energy Corp. He has been a Director of Great Prairie Energy Services Inc. since December 20, 2013. He has been a Director of Ikkuma Resources Corp. since May 22, 2014. He served as a Director at DevCorp Capital Inc. since February 4, 2011. He served as a Director of Chinook Tyee Industry Limited from January 1997 to October 3, 2005. He received a Chartered Accounting designation in 1992. He graduated from the University of Calgary with a Bachelor of Commerce in 1989.



Mr. Joel Stewart Dumaresq is a businessperson who founded Matrix Partners, Inc. and Pashleth Merchant Capital Corp. and who has been the head of 9 different companies. Presently, Mr. Dumaresq holds the position of Chairman & Chief Executive Officer of Organic Flower Investments.  Mr. Dumaresq brings 30 years’ experience in the financial sector, holding financial and investment management roles with RBC Dominion Securities, and was a managing director of Vancouver‐based private equity and merchant banking firm Matrix Partners Inc for 12 years. 


Mr. Dumaresq has extensive operational and senior management experience in the forestry, mining and energy spaces. He is presently an advisor to and an investor in, a range of Cannabis and CBD‐related businesses. Mr. Dumaresq received an undergraduate degree from the University of British Columbia and an undergraduate degree from Harvard University.


CANNABIS SECTOR – IN THE NEWS


In this section, the aim is to keep apprised of updates and advancements in the Cannabis sector and more importantly specific news items that are germane to Experion’s business and focus.  We have one such item to share this weekend, relating to the cannabis derivatives market


‘’Companies That Turn Plants into Oil and Derivative Products is Where Value will be Created in the Cannabis Industry’’


Please take a minute to select the link and listen to an interview with Paul Pedersen of Nextleaf Solutions.  https://www.bnnbloomberg.ca/investment-trends/video/companies-that-turn-plants-into-oil-and-derivative-products-is-where-value-will-be-created-in-the-cannabis-industry~1666842


How Is This Relevant to Experion, you ask?


On October 9, 2018, Experion announced that the Company had received an amended license from Health Canada allowing for the production and possession of cannabis oil (link to news release below).  This licensing achievement was a seminal first step for Experion to participate in the cannabis derivatives market


https://www.viridiumpacific.com/experion-receives-license-to-extract-and-product-cannabis-oil/


Mr. Jarrett Malnarick formerly CEO, now COO commented, ‘’We believe that a great deal of the next generation of cannabis products will be designed around cannabis extracts.  Experion has achieved another important milestone with the extraction amendment, which brings our company another step closer to our vision of building a leading, integrated cannabis company, operating across Canadian and International markets.”


CLOSING ARGUMENT


TODAY I WILL DO WHAT OTHERS WON'T – SO TOMORROW I CAN DO WHAT OTHERS CAN'T


Jerry Rice


The Case for Viridium/Experion:  Unique Advantage born out of thought leadership in the early phases to seek out and acquire a comprehensive set of licenses to supply all markets – today Experion is licensed for everything from R&D to distribution, for consumer markets and B2B


In essence, following the ‘’Jerry Rice Doctrine’’ Doing today what others won’t so that tomorrow we can do what others can’t… 


Viridium’s corporate growth strategy and vision are to build an industry-leading vertically integrated premium cannabis company through established supply chain and production methods, premium well-positioned consumer brands and through strategic partnerships for global operations.


When compared to peer groups, there is no doubt that Viridium is significantly undervalued on a market cap basis, revenue and on a share traded volume.  As a result, we believe that Viridium is therefore poised for significant stock price appreciation once Viridium starts trading in line with its peers.


Are We There Yet? – Trading in Line with Our Peers? – When will we get There?


Not quite – but we are on the road and are very much aware of the journey.  We have key investor awareness and marketing initiatives being set in place to garner a wider audience.  Management will continue to focus and execute its business plan and Investor Relations activities will communicate our accomplishments.  


Jay Garnett brought me on board for this sole purpose, commenting in the Company’s April 15th news release, “Viridium has made significant strides recently; our premium brands, quality operations and disciplined approach to growth will now be supported with a focused internal communications and outreach program. With Ms. Pottinger’s support and guidance, we will be able to more effectively connect Viridium’s story to the investment community while allowing our Senior Management team to focus on building our business.” 


Please Stay Tuned, and If you have not already done so, please join the Viridium portal on 8020 Connect http://connects.digital/Viridium8 and share the link – Let’s Not Keep VIR a Secret Any Longer!!!!


 

!
Thumb year end 2017

Darren Stewart replied to the press release Judy-Ann Pottinger  update in EXPERION HOLDINGS LTD. (TO BE CLOSED)

2 months

2 months

Darren Stewart posted a press release IN CASE YOU MISSED IT in EXPERION HOLDINGS LTD. (TO BE CLOSED)

Dear Investor  


IN CASE YOU MISSED IT


In a press release on Monday, May 13th – Viridium announced that the company had joined the 8020 Connect Investor Community and announced the Company’s AGM to be held on Friday, May 31, 2019


THE AGM


One of the matters to be considered at the AGM will be the election of Directors, each director of the Corporation is elected annually and holds office until the next AGM.  We have three new Directors being considered at the upcoming AGM – Michael Black, Michael Kohut, and Joel Dumaresq.  Having received several questions and request for additional information on these three new directors, we are providing a more detailed Bio for each of Michael Black, Michael Kohut, and Joel Dumaresq. 



Michael J. Black is the senior energy Partner in Fasken’s Calgary office. With significant experience leading large and complex M&A transactions, including several multi-billion-dollar M&A deals, Mr. Black is counsel to numerous domestic and international energy companies. Both clients and peers recognize him as a leading, results-oriented advisor.  Mr. Black has worked exclusively in the energy field, both in private practice and as in-house counsel, with a comprehensive focus on the upstream, midstream and the service sectors of the oil and gas business.  Mr. Black also negotiates and drafts a wide variety of domestic and international energy agreements, including joint operating, acquisition, joint venture, product marketing, and transportation, as well as farm-outs and production sharing contracts.  Having negotiated and closed transactions in over 20 countries, Mr. Black is an expert in providing legal and commercial advice in numerous jurisdictions. He was also the General Counsel of the state-owned oil and gas corporation in the State of Qatar. This combined with his extensive hands-on experience, both in private practice and as in-house counsel, allows him to be fully aligned with clients’ business objectives.


Mr. Black is a graduate of the Institute of Corporate Directors in Canada. Michael has been on the board of eight different companies, including roles as both Chairman of the Board and the Chairman of various committees. He is currently a director of two publicly traded companies.



Mr. Michael G. Kohut serves as the Senior Vice President and Chief Financial Officer at Canadian International Oil Corp. since February 2019. Mr. Kohut has been Chairman of Briko Energy Corp since April 11, 2019. Mr. Kohut was the President and Chief Executive Officer of Briko Energy Corp until April 11, 2019. He has been Chairman of the Board at Big Rock Brewery Inc. since November 9, 2017. He was the Vice President of Finance at Paramount Resources Ltd. from November 23, 2017, to April 2018. Mr. Kohut was the Chief Financial Officer of Paramount Resources (Trilogy Energy Corp) Ltd. since June 1, 2006, to October 2017. Mr. Kohut has over 15 years’ experience in financial management. Mr. Kohut served as President of Chinook Tyee Industry Limited (formerly, Global Railway Industries Ltd.) from January 1997 to October 3, 2005, and Chief Executive Officer until October 3, 2005. He served as Senior Tax Manager of KPMG in Calgary. He has been a Director of Big Rock Brewery Inc. since March 7, 2008, and Panterra Resource Corp. since May 22, 2014. He serves as an Independent Director at West Valley Energy Corp. He has been a Director of Great Prairie Energy Services Inc. since December 20, 2013. He has been a Director of Ikkuma Resources Corp. since May 22, 2014. He served as a Director at DevCorp Capital Inc. since February 4, 2011. He served as a Director of Chinook Tyee Industry Limited from January 1997 to October 3, 2005. He received a Chartered Accounting designation in 1992. He graduated from the University of Calgary with a Bachelor of Commerce in 1989.



Mr. Joel Stewart Dumaresq is a businessperson who founded Matrix Partners, Inc. and Pashleth Merchant Capital Corp. and who has been the head of 9 different companies. Presently, Mr. Dumaresq holds the position of Chairman & Chief Executive Officer of Organic Flower Investments.  Mr. Dumaresq brings 30 years’ experience in the financial sector, holding financial and investment management roles with RBC Dominion Securities, and was a managing director of Vancouver‐based private equity and merchant banking firm Matrix Partners Inc for 12 years. 


Mr. Dumaresq has extensive operational and senior management experience in the forestry, mining and energy spaces. He is presently an advisor to and an investor in, a range of Cannabis and CBD‐related businesses. Mr. Dumaresq received an undergraduate degree from the University of British Columbia and an undergraduate degree from Harvard University.


CANNABIS SECTOR – IN THE NEWS


In this section, the aim is to keep apprised of updates and advancements in the Cannabis sector and more importantly specific news items that are germane to Experion’s business and focus.  We have one such item to share this weekend, relating to the cannabis derivatives market


‘’Companies That Turn Plants into Oil and Derivative Products is Where Value will be Created in the Cannabis Industry’’


Please take a minute to select the link and listen to an interview with Paul Pedersen of Nextleaf Solutions.  https://www.bnnbloomberg.ca/investment-trends/video/companies-that-turn-plants-into-oil-and-derivative-products-is-where-value-will-be-created-in-the-cannabis-industry~1666842


How Is This Relevant to Experion, you ask?


On October 9, 2018, Experion announced that the Company had received an amended license from Health Canada allowing for the production and possession of cannabis oil (link to news release below).  This licensing achievement was a seminal first step for Experion to participate in the cannabis derivatives market


https://www.viridiumpacific.com/experion-receives-license-to-extract-and-product-cannabis-oil/


Mr. Jarrett Malnarick formerly CEO, now COO commented, ‘’We believe that a great deal of the next generation of cannabis products will be designed around cannabis extracts.  Experion has achieved another important milestone with the extraction amendment, which brings our company another step closer to our vision of building a leading, integrated cannabis company, operating across Canadian and International markets.”


CLOSING ARGUMENT


TODAY I WILL DO WHAT OTHERS WON'T – SO TOMORROW I CAN DO WHAT OTHERS CAN'T


Jerry Rice


The Case for Viridium/Experion:  Unique Advantage born out of thought leadership in the early phases to seek out and acquire a comprehensive set of licenses to supply all markets – today Experion is licensed for everything from R&D to distribution, for consumer markets and B2B


In essence, following the ‘’Jerry Rice Doctrine’’ Doing today what others won’t so that tomorrow we can do what others can’t… 


Viridium’s corporate growth strategy and vision are to build an industry-leading vertically integrated premium cannabis company through established supply chain and production methods, premium well-positioned consumer brands and through strategic partnerships for global operations.


When compared to peer groups, there is no doubt that Viridium is significantly undervalued on a market cap basis, revenue and on a share traded volume.  As a result, we believe that Viridium is therefore poised for significant stock price appreciation once Viridium starts trading in line with its peers.


Are We There Yet? – Trading in Line with Our Peers? – When will we get There?


Not quite – but we are on the road and are very much aware of the journey.  We have key investor awareness and marketing initiatives being set in place to garner a wider audience.  Management will continue to focus and execute its business plan and Investor Relations activities will communicate our accomplishments.  


Jay Garnett brought me on board for this sole purpose, commenting in the Company’s April 15th news release, “Viridium has made significant strides recently; our premium brands, quality operations and disciplined approach to growth will now be supported with a focused internal communications and outreach program. With Ms. Pottinger’s support and guidance, we will be able to more effectively connect Viridium’s story to the investment community while allowing our Senior Management team to focus on building our business.” 


Please Stay Tuned, and If you have not already done so, please join the Viridium portal on 8020 Connect http://connects.digital/Viridium8 and share the link – Let’s Not Keep VIR a Secret Any Longer!!!!


 

!

Judy-Ann Pottinger posted a press release IN CASE YOU MISSED IT in EXPERION HOLDINGS LTD. (TO BE CLOSED)

Dear Investor  


IN CASE YOU MISSED IT


In a press release on Monday, May 13th – Viridium announced that the company had joined the 8020 Connect Investor Community and announced the Company’s AGM to be held on Friday, May 31, 2019


THE AGM


One of the matters to be considered at the AGM will be the election of Directors, each director of the Corporation is elected annually and holds office until the next AGM.  We have three new Directors being considered at the upcoming AGM – Michael Black, Michael Kohut, and Joel Dumaresq.  Having received several questions and request for additional information on these three new directors, we are providing a more detailed Bio for each of Michael Black, Michael Kohut, and Joel Dumaresq. 



Michael J. Black is the senior energy Partner in Fasken’s Calgary office. With significant experience leading large and complex M&A transactions, including several multi-billion-dollar M&A deals, Mr. Black is counsel to numerous domestic and international energy companies. Both clients and peers recognize him as a leading, results-oriented advisor.  Mr. Black has worked exclusively in the energy field, both in private practice and as in-house counsel, with a comprehensive focus on the upstream, midstream and the service sectors of the oil and gas business.  Mr. Black also negotiates and drafts a wide variety of domestic and international energy agreements, including joint operating, acquisition, joint venture, product marketing, and transportation, as well as farm-outs and production sharing contracts.  Having negotiated and closed transactions in over 20 countries, Mr. Black is an expert in providing legal and commercial advice in numerous jurisdictions. He was also the General Counsel of the state-owned oil and gas corporation in the State of Qatar. This combined with his extensive hands-on experience, both in private practice and as in-house counsel, allows him to be fully aligned with clients’ business objectives.


Mr. Black is a graduate of the Institute of Corporate Directors in Canada. Michael has been on the board of eight different companies, including roles as both Chairman of the Board and the Chairman of various committees. He is currently a director of two publicly traded companies.



Mr. Michael G. Kohut serves as the Senior Vice President and Chief Financial Officer at Canadian International Oil Corp. since February 2019. Mr. Kohut has been Chairman of Briko Energy Corp since April 11, 2019. Mr. Kohut was the President and Chief Executive Officer of Briko Energy Corp until April 11, 2019. He has been Chairman of the Board at Big Rock Brewery Inc. since November 9, 2017. He was the Vice President of Finance at Paramount Resources Ltd. from November 23, 2017, to April 2018. Mr. Kohut was the Chief Financial Officer of Paramount Resources (Trilogy Energy Corp) Ltd. since June 1, 2006, to October 2017. Mr. Kohut has over 15 years’ experience in financial management. Mr. Kohut served as President of Chinook Tyee Industry Limited (formerly, Global Railway Industries Ltd.) from January 1997 to October 3, 2005, and Chief Executive Officer until October 3, 2005. He served as Senior Tax Manager of KPMG in Calgary. He has been a Director of Big Rock Brewery Inc. since March 7, 2008, and Panterra Resource Corp. since May 22, 2014. He serves as an Independent Director at West Valley Energy Corp. He has been a Director of Great Prairie Energy Services Inc. since December 20, 2013. He has been a Director of Ikkuma Resources Corp. since May 22, 2014. He served as a Director at DevCorp Capital Inc. since February 4, 2011. He served as a Director of Chinook Tyee Industry Limited from January 1997 to October 3, 2005. He received a Chartered Accounting designation in 1992. He graduated from the University of Calgary with a Bachelor of Commerce in 1989.



Mr. Joel Stewart Dumaresq is a businessperson who founded Matrix Partners, Inc. and Pashleth Merchant Capital Corp. and who has been the head of 9 different companies. Presently, Mr. Dumaresq holds the position of Chairman & Chief Executive Officer of Organic Flower Investments.  Mr. Dumaresq brings 30 years’ experience in the financial sector, holding financial and investment management roles with RBC Dominion Securities, and was a managing director of Vancouver‐based private equity and merchant banking firm Matrix Partners Inc for 12 years. 


Mr. Dumaresq has extensive operational and senior management experience in the forestry, mining and energy spaces. He is presently an advisor to and an investor in, a range of Cannabis and CBD‐related businesses. Mr. Dumaresq received an undergraduate degree from the University of British Columbia and an undergraduate degree from Harvard University.


CANNABIS SECTOR – IN THE NEWS


In this section, the aim is to keep apprised of updates and advancements in the Cannabis sector and more importantly specific news items that are germane to Experion’s business and focus.  We have one such item to share this weekend, relating to the cannabis derivatives market


‘’Companies That Turn Plants into Oil and Derivative Products is Where Value will be Created in the Cannabis Industry’’


Please take a minute to select the link and listen to an interview with Paul Pedersen of Nextleaf Solutions.  https://www.bnnbloomberg.ca/investment-trends/video/companies-that-turn-plants-into-oil-and-derivative-products-is-where-value-will-be-created-in-the-cannabis-industry~1666842


How Is This Relevant to Experion, you ask?


On October 9, 2018, Experion announced that the Company had received an amended license from Health Canada allowing for the production and possession of cannabis oil (link to news release below).  This licensing achievement was a seminal first step for Experion to participate in the cannabis derivatives market


https://www.viridiumpacific.com/experion-receives-license-to-extract-and-product-cannabis-oil/


Mr. Jarrett Malnarick formerly CEO, now COO commented, ‘’We believe that a great deal of the next generation of cannabis products will be designed around cannabis extracts.  Experion has achieved another important milestone with the extraction amendment, which brings our company another step closer to our vision of building a leading, integrated cannabis company, operating across Canadian and International markets.”


CLOSING ARGUMENT


TODAY I WILL DO WHAT OTHERS WON'T – SO TOMORROW I CAN DO WHAT OTHERS CAN'T


Jerry Rice


The Case for Viridium/Experion:  Unique Advantage born out of thought leadership in the early phases to seek out and acquire a comprehensive set of licenses to supply all markets – today Experion is licensed for everything from R&D to distribution, for consumer markets and B2B


In essence, following the ‘’Jerry Rice Doctrine’’ Doing today what others won’t so that tomorrow we can do what others can’t… 


Viridium’s corporate growth strategy and vision are to build an industry-leading vertically integrated premium cannabis company through established supply chain and production methods, premium well-positioned consumer brands and through strategic partnerships for global operations.


When compared to peer groups, there is no doubt that Viridium is significantly undervalued on a market cap basis, revenue and on a share traded volume.  As a result, we believe that Viridium is therefore poised for significant stock price appreciation once Viridium starts trading in line with its peers.


Are We There Yet? – Trading in Line with Our Peers? – When will we get There?


Not quite – but we are on the road and are very much aware of the journey.  We have key investor awareness and marketing initiatives being set in place to garner a wider audience.  Management will continue to focus and execute its business plan and Investor Relations activities will communicate our accomplishments.  


Jay Garnett brought me on board for this sole purpose, commenting in the Company’s April 15th news release, “Viridium has made significant strides recently; our premium brands, quality operations and disciplined approach to growth will now be supported with a focused internal communications and outreach program. With Ms. Pottinger’s support and guidance, we will be able to more effectively connect Viridium’s story to the investment community while allowing our Senior Management team to focus on building our business.” 


Please Stay Tuned, and If you have not already done so, please join the Viridium portal on 8020 Connect http://connects.digital/Viridium8 and share the link – Let’s Not Keep VIR a Secret Any Longer!!!!


 

!

Experion Holdings Ltd. (to be closed)

lockPrivate Group

Please join the new Experion Group on 8020 Connect. https://www.8020connect.com/groups/experion-holdings-ltd

people29 Members       (0)

Corporate Profile
Group Admins:
  • Thumb 8020 monitor 200200 2
  • Thumb 20190424 083700 film4 1
Request Membership


Experion Holdings Ltd. (to be closed)

lockPrivateGroup

Please join the new Experion Group on 8020 Connect. https://www.8020connect.com/groups/experion-holdings-ltd ...

people29 Members       (0)

Judy-Ann Pottinger posted an update EXPERION - IMPORTANT GROUP NOTICE WE ARE MOVING PLEASE COME WITH US in EXPERION HOLDINGS LTD. (TO BE CLOSED)

In order for Experion Holdings Ltd, to fully move our brand from our old name Viridium Pacific to Experion Holdings, disclosed in our new release dated June 10th, 2019, we asked 8020 to launch a new group. Our 8020 group had a URL with the Viridium name displayed, and as such we asked that the group be changed to the display URL using our new Experion Holdings name.


Please join the new group by clicking the link, before the old group is deleted from the 8020 site. http://connects.company/ExperionEXP


Thank you


Judy-Ann Pottinger


IR Manager, Experion Holdings Ltd.


 

!
Thumb 8020 monitor 200200 2

8020Admin

7 days

8020Admin posted a press release Experion Holdings Ltd. Trading on Frankfurt Stock Exchange Under New Company Name in EXPERION HOLDINGS LTD. (TO BE CLOSED)

VANCOUVER, BC / ACCESSWIRE / July 3, 2019 / Experion Holdings Ltd. ("Experion" or the "Company") (TSXV: EXP) (OTCQB:EXPFF) (FRANKFURT:MB31), formerly Viridium Pacific Group Ltd., announced today that its shares are now trading on the Frankfurt Stock Exchange under the Company's new name Experion Holdings Ltd. The symbol and WKN have not changed and remains ''MB31" and ''WKN:A2PLZG".


The Company's shares continue to be listed on the TSXV under the ticker ''EXP" and on the OTCQB market in the US under the ticker "EXPFF"


Mr. Jay Garnett, Chief Executive Officer commented, "Experion is pursuing international growth strategies, such as the vast export market in countries with early opportunities. Having our new name reflected on the Frankfurt Stock Exchange will allow us to grow our shareholder base throughout Europe and attract global recognition as we work diligently to unlock value for our current shareholders and new shareholders to come"


The Frankfurt Stock Exchange is one of the world's largest trading centres for securities. With a share in turnover of around 90 per cent, it is the largest of Germany's seven stock exchanges and it is an international trading centre, which is reflected in the structure of its participants. Of the approximately 200 market participants, roughly 50% are from countries other than Germany.


On June 25th Experion announced an LOI with a Polish Import and Distribution Company. The LOI will see Experion exporting medical flower products to Poland for scientific purposes enabling the Polish Company to test and develop Experion's flower products. Ultimately Experion's goal is to export increased quantities of its flower products into Poland for medical use.


Mr. Jay Garnett further commented "As investor interest and momentum in the cannabis industry continues to accelerate, Experion will be well-positioned to participate in the European and global cannabis markets as they continue to expand, and we receive our EU GMP certification that will allow Experion products to be exported across Europe."


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's website www.experionwellness.com or contact:


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com


We invite all investors and other interested parties to join the Experion Holdings portal on 8020 Connect. Join here: http://connects.company/Experion


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Experion Holdings Ltd.


View source version on accesswire.com:
https://www.accesswire.com/550713/Experion-Holdings-Ltd-Trading-on-Frankfurt-Stock-Exchange-Under-New-Company-Name

!
Thumb 8020 monitor 200200 2

8020Admin

15 days

8020Admin posted a press release Experion Announces Letter of Intent with Polish Import and Distribution Company in EXPERION HOLDINGS LTD. (TO BE CLOSED)

VANCOUVER, BC / ACCESSWIRE / June 25, 2019 / Experion Holdings Ltd. ("Experion" or the "Company") (TSXV: EXP) (OTCQB:EXPFF) (FRANKFURT:MB31), formerly Viridium Pacific Group Ltd., is pleased to announce that it has signed a non-binding Letter of Intent (''LOI'') with a Polish Import and distribution Company (''Polish Company'') to export medical flower products to Poland for scientific purposes.


The executed LOI consist of two parts, part one, will see Experion exporting medical flower products to Poland for scientific purposes enabling the Polish Company to test and develop Experion's flower products. Upon the successful testing and development of the flower products and once a viable export and import channel has been established between Canada and Poland, part two of the LOI will commence which will see Experion exporting increased quantities of its flower products into Poland for medical use. Experion will also have completed its EU GMP certification which will allow for part two of the LOI.


Mr. Jay Garnett, Chief Executive Officer commented, "The LOI represents a major milestone for Experion. As medical marijuana becomes more legalized around the world, Experion continues to focus on the vast export market in countries with early opportunities. By exporting products for scientific research, we are able to move past barriers to entry and be one of the first Canadian producers to enter Poland"


Pursuant to the LOI, Experion and the Polish Import Company will work towards a definitive agreement as Experion seeks to increase export opportunities in Europe and continue to build Experion's international distribution chain.


Mr. Jay Garnett further commented "I am truly proud of the work that the team has done and the great strides we have made to date. This is yet another result of solid teamwork that can only be achieved by having a shared vision and goal as we work diligently to unlock value for our most important asset and audience - our shareholders.


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's website www.experionwellness.com or contact:


Experion Holdings Ltd


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com


We invite all investors and other interested parties to join the Experion Holdings portal on 8020 Connect. Join here: http://connects.company/Experion


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Experion Holdings Ltd.


View source version on accesswire.com:
https://www.accesswire.com/549774/Experion-Announces-Letter-of-Intent-with-Polish-Import-and-Distribution-Company

!
Thumb 8020 monitor 200200 2

8020Admin

19 days

8020Admin posted a press release Experion's Brand, Kanabé Goods Co., Well Positioned to Take Advantage of New Health Canada Regulations in EXPERION HOLDINGS LTD. (TO BE CLOSED)


VANCOUVER, BC / ACCESSWIRE / June 21, 2019 / Experion Holdings Ltd. ("Experion" or the "Company") (TSXV: EXP) (OTCQB:EXPFF), formerly Viridium Pacific Group Ltd., is pleased to provide an update on the Company's brands positioned to take advantage of Health Canada's final regulations for Value-Add Products (VAP's) such as cannabis topicals, edibles and extracts as well as Health Canada's proposal to create a new category ''Cannabis Health Products'' for therapeutic treatment of minor ailments like sleeplessness or sore muscles or for use in pets, paving the way for large new untapped market.


Mr. Jay Garnett, Chief Executive Officer commented "Experion is in continued development of our wellness-centric brand Kanabé Goods Co. www.kanabe.ca for the launch of value-add products (VAP's). There are currently 50 plus existing formulations which we have the ability to produce in our facility and we are also working with key strategic partners for large scale commercial roll-out. These health and wellness products such as non-intoxicating topicals and micro-dosed oils are an entry point for new consumers, broadening the market potential. The Experion management team has decades of experience in consumer-packaged goods and is well positioned to be a first mover in this category which in turn will enable Experion to stand firm in our commitment of unlocking value for our shareholders"


The VAP's regulations come into force October 17, 2019 with product availability earliest December 16th, 2019. Furthermore, Health Canada's proposal for Cannabis Health Products opens the door for a bigger opportunity. The proposal looks to treat health and wellness products with cannabis, similar to Natural Health Products which allows the product to make health claims based on evidence but without the oversight of a practitioner.


Mr. Garnett further commented "A Kanabé topical balm that is non-intoxicating, for example, could potentially be sold via pharmacies or online without the restrictions to have a medical cannabis prescription or buy through a licensed cannabis retailer. The accessibility to purchase is much easier on the consumer, as well as the use of the product much clearer." This proposal further aligns to our educational and public outreach efforts from our Cannabis Wellness Expert and Co-Founder of Kanabé, Krystal Laferriere, who had created the product line to soothe side-effects and other ailments suffered as a result of her Crohn's Disease."


Health Canada is asking the public to submit feedback on this new category via consultation paper until September 3rd.


https://www.canada.ca/en/health-canada/programs/consultation-potential-market-cannabis.html


Health Canada Final Regulations for Value-Add Products


https://www.canada.ca/en/health-canada/news/2019/06/health-canada-finalizes-regulations-for-the-production-and-sale-of-edible-cannabis-cannabis-extracts-and-cannabis-topicals.html


About Kanabe Goods Co


Kanabé Goods Co. www.kanabe.ca creates therapeutic health and wellness products containing cannabis and has over 50 formulations in its portfolio including topical salves, lotions, oils as well as edible oils and capsules. Kanabé products were developed to target and soothe various aliments by combining cannabinoids, terpenes and aromatherapy with a focus on discretion and ease of use by developing products that are already found in consumers everyday life. Kanabé is an adult-use, over-the-counter health & wellness brand ingraining into daily actions and rituals for comfort and solutions to acute problems ranging from sore muscles, to sleep and skin issues.


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's website www.experionwellness.com or contact:


Experion Holdings Ltd
Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com


We invite all investors and other interested parties to join the Experion Holdings portal on 8020 Connect. Join here: http://connects.company/Experion


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Experion Holdings Ltd


View source version on accesswire.com:
https://www.accesswire.com/549436/Experions-Brand-Kanab-Goods-Co-Well-Positioned-to-Take-Advantage-of-New-Health-Canada-Regulations

!

Experion begins trading on OTCQB Venture Market – The Case for Experion – MY TAKE

Members, I hope you saw the news issued yesterday that Experion is now trading on the OTCQB in complement, to our TSX V listing, this is great for EXP for several reasons. The most important is the fact is that we now have a direct presence among American retail and institutional investors, which will, in turn, allow quotation access to USA investment advisors. This new access opens the door to USA investment that was not easily accessible before when trading solely on a Canadian trading platform. American registered retail advisors, who don't have direct quotation access to Canadian issuers, are reluctant to look at the possibility of investment for their clientele, as they cannot get an instant quotation, and direct trading. Now with our new listing on the OTCQB, this will provide all American retail and institutional advisors real-time quotes and a trading platform in the USA.

!

Experion begins trading on OTCQB Venture Market – The Case for Experion – MY TAKE

Members, I hope you saw the news issued yesterday that Experion is now trading on the OTCQB in complement, to our TSX V listing, this is great for EXP for several reasons. The most important is the fact is that we now have a direct presence among American retail and institutional investors, which will, in turn, allow quotation access to USA investment advisors. This new access opens the door to USA investment that was not easily accessible before when trading solely on a Canadian trading platform. American registered retail advisors, who don't have direct quotation access to Canadian issuers, are reluctant to look at the possibility of investment for their clientele, as they cannot get an instant quotation, and direct trading. Now with our new listing on the OTCQB, this will provide all American retail and institutional advisors real-time quotes and a trading platform in the USA.

!
Thumb 8020 monitor 200200 2

8020Admin

21 days

8020Admin posted a press release Experion Holdings Ltd Announces Its U.S. Listing on OTCQB Under the Symbol EXPFF in EXPERION HOLDINGS LTD. (TO BE CLOSED)

VANCOUVER, BC / ACCESSWIRE / June 19, 2019 / Experion Holdings Ltd. ("Experion" or the  "Company") (TSX-V: EXP) (OTCQB: EXPFF), formerly Viridium Pacific Group Ltd., today announced it has qualified to trade on the OTCQB Venture Market. Experion also has the intention to seek The Depositary Trust Company ("DTC") eligibility.


The common shares of Experion will begin trading on the OTCQB, effective immediately, under the ticker symbol "EXPFF." U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.


Mr. Jay Garnett, Chief Executive Officer, commented "We are proud to qualify for a listing on the OTCQB marketplace.  This is an important step and milestone for the Company as it aims to increase its presence among American retail and institutional investors. This move will provide investors with additional liquidity and increased trading capacity and reaffirms to the markets that we are indeed committed to unlocking value for our shareholders".


Experion will continue to trade on the TSX Venture Exchange under its existing symbol "EXP".


About OTCQB Venture


The OTCQB Venture is the premier marketplace for entrepreneurial and development stage U.S. and international companies that are committed to providing a high-quality trading and information experience for their US investors. To be eligible, companies must be current in their financial reporting, pass a minimum bid price test, and undergo an annual company verification and management certification process. The OTCQB Venture quality standards provide a strong baseline of transparency, as well as the technology and regulation to improve the information and trading experience for investors.


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB. 


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


Experion Holdings Ltd 


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com 


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Experion Holdings Ltd.



View source version on accesswire.com:
https://www.accesswire.com/549207/Experion-Holdings-Ltd-Announces-Its-US-Listing-on-OTCQB-Under-the-Symbol-EXPFF

!

Good morning Experion members, a great article to share with you as it is very germane to the work Experion has done and is continuing to do. Experion is working to get ready for value-add products legislation through its brand, Kanabe Goods Co. which formulates topicals and micro-dosed oils targeted at the wellness and therapeutic market.

https://www.cbc.ca/news/politics/marijuana-cannabis-edibles-extracts-vaping-1.5174844?fbclid=IwAR1rllpsYIkmQy309cMGQRumgRPYRwTUpsNn97y9avch0sUMPXTJmYJrt1Y

!
Thumb 8020 monitor 200200 2

8020Admin

23 days

8020Admin posted a press release Experion Announces Resignation of Board Member in EXPERION HOLDINGS LTD. (TO BE CLOSED)

VANCOUVER, BRITISH COLUMBIA / ACCESSWIRE / June 17, 2019 / Experion Holdings Ltd. ("Experion" or the "Company") (TSXV: EXP), formerly Viridium Pacific Group Ltd., wishes to announce that Michael Kohut has resigned from the board of directors of Experion effectively immediately.


Mr. Jay Garnett, Chief Executive Officer, commented, "We would like to thank Mike for his efforts and contributions. We are in the process of evaluating candidates that will strengthen our board and support management in unlocking value for all shareholders."


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


Experion Holdings Ltd


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com


SOURCE: Experion Holdings Ltd.


View source version on accesswire.com:
https://www.accesswire.com/548952/Experion-Announces-Resignation-of-Board-Member

!
Thumb 8020 monitor 200200 2

8020Admin

29 days

8020Admin posted a press release Experion Adds Veteran Financial and Business Magnate to Board of Directors with the Appointment of William (Bill) Kenneth Dickie in EXPERION HOLDINGS LTD. (TO BE CLOSED)

VANCOUVER, BC / ACCESSWIRE / June 11, 2019 / Experion Holdings Ltd. ("Experion" or the "Company") (TSX-V: EXP), formerly Viridium Pacific Group Ltd., is pleased to announce the appointment of a new member to its Board of Directors. Mr. William (Bill) Kenneth Dickie will join Mr. Jay Garnett, Chief Executive Officer of Experion Holdings Ltd, on the Board of Directors effective June 11, 2019.


Mr. Dickie brings substantial financial oversight and business advisory experience to Experion's Board. Mr. Dickie is currently, the Co‐Chief Investment Officer and a Portfolio Manager at Matco Financial, a Calgary, Alberta based independent discretionary investment counsellor and asset management firm. Mr. Dickie has over thirty-five (35) years of experience in the financial and investment industry, and is responsible for the investment operations and strategic development of Matco Financial Inc. He is a member of the Investment Committee, Asset Mix Committee and Chair of the Equity Working Group. As the Co-Chief Investment Officer of Matco Financial Inc., he has oversight of the Matco Investment Platform.


Mr. Dickie has been helping private clients achieve their goals since 1979, starting his career with McLeod Young Weir Ltd. Prior to co-founding Matco Financial Inc. in 2006, Mr. Dickie was President and Director of Fiduciary Trust Company of Canada, formerly part of Bissett Investment Management. where he established a new business strategy and model. Mr. Dickie graduated from the University of Alberta having earned a Bachelor of Commerce and holds the Chartered Financial Analyst designation.


"Bill brings a wealth of financial and governance expertise" said Jay Garnett, CEO of Experion Holding Ltd. "his appointment furthers our commitment to a strong and relevant board. Bill's addition to the Board is significant as he brings deep knowledge of the cannabis industry through his role as Co-Chief Investment Officer and one of the Lead Portfolio Managers of the Matco's Cannabis Fund; as well as extensive financial and deal-making skills. His firsthand approach to mentoring and building new companies in fast growing industries will be invaluable to Experion. We look forward to Bill's guidance as we continue to execute on our strategic objectives for 2019 to unlock value and grow Experion's market valuation."


Mr. Dickie was an early investor in EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, Alberta, which Experion acquired in February 2019.


Mr. Dickie commented, "I am pleased to be joining the Board of Experion at this important inflection point in the Company's history within an exciting and dynamic market environment. As Experion embarks on a period of tremendous growth and differentiation, I look forward to working with Jay and the management team".


Resignation of Sean McNeil


Mr. Sean MacNeil has recently resigned from his position as a Director on Experion's Board of Directors to focus on other matters. Mr. Jay Garnett added, "We wish to sincerely thank Sean for his important contributions as a key contributor in the Company's evolution and growth over the last several years. We wish him well in his future endeavors."


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


Experion Holdings Ltd


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Experion Holdings Ltd


View source version on accesswire.com:
https://www.accesswire.com/548360/Experion-Adds-Veteran-Financial-and-Business-Magnate-to-Board-of-Directors-with-the-Appointment-of-William-Bill-Kenneth-Dickie

!
Thumb 8020 monitor 200200 2

8020Admin

30 days

8020Admin posted a press release Viridium Pacific Group Ltd. Announces Name Change to Experion Holdings Ltd. in EXPERION HOLDINGS LTD. (TO BE CLOSED)

VANCOUVER, BC / ACCESSWIRE / June 10, 2019 / Viridium Pacific Group Ltd. (the ''Company") (TSX-V: VIR ) is pleased to announce that the Company has changed its name from "Viridium Pacific Group Ltd." to "Experion Holdings Ltd." (TSX-V: EXP).The Company's shareholders approved the name change at a special meeting of shareholders held on May 31, 2019. Effective on market opening on June 10, 2019, the common shares of the Company will commence trading on the TSX Venture Exchange under the Company's new name, Experion Holdings Ltd., and under the trading symbol ''EXP". With the new change in name, there is no consolidation of capital and the CUSIP Number will be 30219B109.


Mr. Jay Garnett, Chief Executive Officer, commented, "We are excited to have both our Licence and corporate entity under Experion. Having a focused brand strategy, under one corporate brand, will bring alignment to the market and our shareholders. In addition, it will allow us to better communicate our value proposition as we work to unlock value and communicate our accomplishments to the market and stakeholders."


No action is required to be taken by current shareholders in connection with the change in name and no change has been made to Experion Holdings Ltd. share capital.


About Experion Holdings Ltd.


Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX Laboratories Inc., a medical products production and clinical research company based in Calgary, AB.


Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


A new Company website will be rolled out in the following weeks, for now please visit www.viridiumpacific.com or contact our Investor Relations Consultant (details below) for further information.


Experion Holdings Ltd


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Viridium Pacific Group Ltd.




View source version on accesswire.com:
https://www.accesswire.com/548214/Viridium-Pacific-Group-Ltd-Announces-Name-Change-to-Experion-Holdings-Ltd

!
Thumb 8020 monitor 200200 2

8020Admin

1 month

8020Admin posted a press release Experion Biotechnologies Inc's Krystal Laferriere Sits on Panel at Lift & Co Expo Consumer Weekend in EXPERION HOLDINGS LTD. (TO BE CLOSED)


VANCOUVER, BRITISH COLUMBIA / ACCESSWIRE / June 8, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (US OTC; VIRFF) the parent company of Experion Biotechnologies Inc. ("Experion"), a Health Canada licensed cultivator and processor of Cannabis is pleased to announce that the Company will take part in a panel discussion at the Lift & Co. Expo Consumer Weekend on June 9th in Toronto.


Krystal Laferriere, Marketing Manager Experion Wellness, will sit on a panel with industry heavyweights such as Dr. Ira Price, Assistant Clinical Professor Emergency Medicine at McMaster University, and NextLeaf Solutions CEO, Paul Pedersen. The panel discussion will take place at the Expo Consumer Weekend on Sunday June 9th at 2:20pm to 3:00pm EST on Cannabis, Clarity & Wellness - New and Overdue Treatments and Therapies.


CEO Jay Garnett commented "We are excited to have Krystal be a key contributor and presenter at the upcoming Lift & Co Expo. Krystal is Experion's ambassador, a trusted and resonant voice in the medical Cannabis space. Krystal has fostered a large following on social media primarily because of her personal struggles with Crohn's disease and her ultimate discovery of cannabis as a therapy. Having Krystal as Experion's Cannabis Wellness Expert spearheading cannabis education, marketing and brand ambassadorship, enables Experion to have an authentic voice as we position Experion to be a dominant producer of a wide spectrum of cannabis products in the near future."


We invite all attendess of the Lift & Co Expo to join us on Sunday, June 9th at 2:20 pm to 3:00 pm.


CEO Jay Garnett further commented "We are excited about the many ways our products can enhance wellness, helping people sleep better and alleviating a range of chronic conditions. We are proud of our progress in the pain management field, particularly with our two-piece pill. It is the only cannabis product in Canada to have reached stage three clinical trials for post-operative pain relief."


Lift & Co. (TSXV: LIFT) is a cannabis-focused technology and media company that monetizes a platform of advertising solutions, events, and data insights to enable cannabis businesses to better understand, target and ultimately monetize cannabis consumers. Lift & Co. operates a leading product-comparison resource of federally regulated cannabis products; provides customized marketing solutions and data-backed insights into consumer and product trends; and connects businesses and consumers through its digital platform, and at its leading events, the Retail Tradeshows, the Lift & Co. Expos and the Canadian Cannabis Awards. The Lift & Co. Cannabis Retail Training Certification, developed in an exclusive partnership with MADD Canada, is available to both government and private clients. Learn more at lift.co.


Viridium Pacific Group Ltd. and its wholly owned subsidiary, Experion Biotechnologies Inc., together with one of its directors and several other named defendants were named in a civil claim filed by an ex-CEO of Viridium, Stephen Serenas. Mr. Serenas is seeking damages among other remedies, for breach of contract and wrongful dismissal for his employment as CEO of Viridium in the form of 10,270,437 shares of Viridium, or, alternatively, $5,546,035 as cash in lieu of the shares; in addition to 149,625 restricted stock units fully vested in Viridium. Management considers this claim to be without merit and both Viridium and Experion intend to vigorously defend the action.


About Viridium


Viridium Pacific Group Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX labs, a medical products production and clinical research company based in Calgary, AB.


Viridium is invested in a portfolio of products including to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's www.viridiumpacific.com or contact:


Viridium Pacific Group Ltd.


Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com
www.viridiumpacific.com


We invite all investors and other interested parties to join the Viridium portal on 8020 Connect. Join here: http://connects.digital/Viridium8.


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Viridium Pacific Group Ltd.


View source version on accesswire.com:
https://www.accesswire.com/548151/Experion-Biotechnologies-Incs-Krystal-Laferriere-Sits-on-Panel-at-Lift-Co-Expo-Consumer-Weekend

!
Thumb 8020 monitor 200200 2

8020Admin

1 month

8020Admin posted a press release Viridium Pacific Group Announces Results Of Annual General Meeting in EXPERION HOLDINGS LTD. (TO BE CLOSED)


VANCOUVER, BC / ACCESSWIRE / June 6, 2019 / Viridium Pacific Group Ltd. ("Viridium" or the "Company") (TSXV: VIR) (US OTC; VIRFF) is pleased to announce the results of its annual general and special meeting of shareholders held on May 31, 2019 (the "Meeting").


The Company put forward the following resolutions to be voted on by shareholders at the Meeting, all of which were approved:


(i) Appointment of MNP LLP, Chartered Professional Accountants as Auditors of the Company for the ensuing year and authorizing the Directors to fix their remuneration.


(ii) Fixing the number of directors of the Company at seven (7);


(iii) The election of directors - 01. Michael Black 02. Joel Dumaresq 03. Deni Echino 04. Jay Garnett 05. Michael Kohut 06. Sean MacNeil 07. Harry McWatters


(iv) Approve a special resolution to change the name of the Corporation to Experion Holdings Ltd.


(v) Approval of the Corporation's stock option plan


Each of the directors elected at the meeting being, Michael Black, Joel Dumaresq, Deni Echino, Jay Garnett, Michael Kohut, Sean MacNeil and Harry McWatters will hold office until the next annual meeting of the Company or until their earlier resignation or removal. Mr. Harry McWatters accepted the role of Chairman for the ensuing year, Mr. Joel Dumaresq was appointed the Audit Chair and Mr. Michael Black was appointed the Compensation and Nominations Chair.


In addition, the Company granted 156,250 Restricted Stock Units ("RSUs") to its directors and a former director, of which 25,000 RSUs will vest on May 31, 2020 and the remaining 131,250 RSUs will vest 12 months after the directors resign.


CEO Jay Garnett commented. "We are pleased to have our board elected with high acceptance of our voting shareholders. Having a strong Board is fundamental to Experion as we move forward with our strategy to unlock value and grow Experion's valuation in the marketplace. Our focused mandate to unlock value in our licenses, in our team and in our strategy gives Experion a sound footing in building a progressive cannabis company regionally, nationally and internationally."


About Viridium


Viridium Pacific Group Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC; and EFX labs, a medical products production and clinical research company based in Calgary, AB.


Viridium is invested in a portfolio of products including to address a wide spectrum of consumer needs' including Medical, Adult-use, and Wellness and Therapeutic products.


For further information, please visit the Company's www.viridiumpacific.com or contact


Viridium Pacific Group Ltd.
Judy-Ann Pottinger, Investor Relations
Tel: (604) 617-5290
judy-ann@experionwellness.com
www.viridiumpacific.com


We invite all investors and other interested parties to join the Viridium portal on 8020 Connect. Join here: http://connects.digital/Viridium8


Disclosure


This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.


Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company's equity securities; recent market volatility; the Company's ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.


SOURCE: Viridium Pacific Group Ltd.


View source version on accesswire.com:
https://www.accesswire.com/547926/Viridium-Pacific-Group-Announces-Results-Of-Annual-General-Meeting

!

Good morning
Please check out this article from Green Chips
Jeff Siegel of Green Chip Stocks known for his skill in picking winning Cannabis stocks says BUY Viridium Pacific (TSX-V:VIR)


insert_drive_fileEXPERION_QA_-Green_Chip_Stocks_FINAL_052719.pdf
Thumb experion qa  green chip stocks final 052719

!

Judy-Ann Pottinger posted an update German medical cannabis market led by older patients; 750 kilograms of flower imported in Q1 in EXPERION HOLDINGS LTD. (TO BE CLOSED)

Dear Investor,


I would like to share an article, excerpt and link below, that speaks to the German medical cannabis market.  The German marketplace described as a ‘’linchpin for many international marijuana companies’’ is an important one for Viridium and in fact, Viridium has already secured entry into the German medical cannabis market.


More than 750 kilograms of medical cannabis flower was imported to Germany in the first quarter of this year, putting the country on pace to import about the same amount in 2019 as it did last year – 3,000 kilograms.


This is according to new data from the government, providing clarity on the actual size of a market that is a linchpin for many international marijuana companies.


https://mjbizdaily.com/german-medical-cannabis-market-led-by-older-patients-750-kg-flower-imported-q1/


Viridium announced on December 27, 2018, that the Company had signed an agreement with INOPHA GmbH a pharmaceutical distributor for the German market to enter the tender process within Germany and acquire a license to cultivate medical cannabis – the link below.


Chief Executive Officer, Jay Garnett, commented: “The German medical cannabis patient relies on high-quality cannabis supply that meets the rigorous standards of regulations, such as those governing our industry in Canada. INOPHA’s interest in working with a Canadian LP, such as Viridium, stems from the need to partner with a proven operator with a track record of supplying the medical market.” Mr. Garnett further stated, “We look forward to working with INOPHA to build a quality medical cannabis producer in Germany.”


https://www.viridiumpacific.com/viridium-signs-agreement-with-german-partner-inopha-entering-the-tender-process-to-cultivate-medical-cannabis-in-germany/


Viridium continues to execute on its business plan, a key and seminal move by Viridium has been to secure the requisite licenses and seek out partnerships that will greatly enhance the Company’s growth domestically and internationally.


Thank you for reading.  Stay Tuned!!!!

!
Thumb b7c819c2f8949d2a4df7a13fade3f5a1 bpfull

DArcy Funfer replied to the press release Judy-Ann Pottinger  update in EXPERION HOLDINGS LTD. (TO BE CLOSED)

2 months

2 months

DArcy Funfer posted a press release IN CASE YOU MISSED IT in EXPERION HOLDINGS LTD. (TO BE CLOSED)

Dear Investor  


IN CASE YOU MISSED IT


In a press release on Monday, May 13th – Viridium announced that the company had joined the 8020 Connect Investor Community and announced the Company’s AGM to be held on Friday, May 31, 2019


THE AGM


One of the matters to be considered at the AGM will be the election of Directors, each director of the Corporation is elected annually and holds office until the next AGM.  We have three new Directors being considered at the upcoming AGM – Michael Black, Michael Kohut, and Joel Dumaresq.  Having received several questions and request for additional information on these three new directors, we are providing a more detailed Bio for each of Michael Black, Michael Kohut, and Joel Dumaresq. 



Michael J. Black is the senior energy Partner in Fasken’s Calgary office. With significant experience leading large and complex M&A transactions, including several multi-billion-dollar M&A deals, Mr. Black is counsel to numerous domestic and international energy companies. Both clients and peers recognize him as a leading, results-oriented advisor.  Mr. Black has worked exclusively in the energy field, both in private practice and as in-house counsel, with a comprehensive focus on the upstream, midstream and the service sectors of the oil and gas business.  Mr. Black also negotiates and drafts a wide variety of domestic and international energy agreements, including joint operating, acquisition, joint venture, product marketing, and transportation, as well as farm-outs and production sharing contracts.  Having negotiated and closed transactions in over 20 countries, Mr. Black is an expert in providing legal and commercial advice in numerous jurisdictions. He was also the General Counsel of the state-owned oil and gas corporation in the State of Qatar. This combined with his extensive hands-on experience, both in private practice and as in-house counsel, allows him to be fully aligned with clients’ business objectives.


Mr. Black is a graduate of the Institute of Corporate Directors in Canada. Michael has been on the board of eight different companies, including roles as both Chairman of the Board and the Chairman of various committees. He is currently a director of two publicly traded companies.



Mr. Michael G. Kohut serves as the Senior Vice President and Chief Financial Officer at Canadian International Oil Corp. since February 2019. Mr. Kohut has been Chairman of Briko Energy Corp since April 11, 2019. Mr. Kohut was the President and Chief Executive Officer of Briko Energy Corp until April 11, 2019. He has been Chairman of the Board at Big Rock Brewery Inc. since November 9, 2017. He was the Vice President of Finance at Paramount Resources Ltd. from November 23, 2017, to April 2018. Mr. Kohut was the Chief Financial Officer of Paramount Resources (Trilogy Energy Corp) Ltd. since June 1, 2006, to October 2017. Mr. Kohut has over 15 years’ experience in financial management. Mr. Kohut served as President of Chinook Tyee Industry Limited (formerly, Global Railway Industries Ltd.) from January 1997 to October 3, 2005, and Chief Executive Officer until October 3, 2005. He served as Senior Tax Manager of KPMG in Calgary. He has been a Director of Big Rock Brewery Inc. since March 7, 2008, and Panterra Resource Corp. since May 22, 2014. He serves as an Independent Director at West Valley Energy Corp. He has been a Director of Great Prairie Energy Services Inc. since December 20, 2013. He has been a Director of Ikkuma Resources Corp. since May 22, 2014. He served as a Director at DevCorp Capital Inc. since February 4, 2011. He served as a Director of Chinook Tyee Industry Limited from January 1997 to October 3, 2005. He received a Chartered Accounting designation in 1992. He graduated from the University of Calgary with a Bachelor of Commerce in 1989.



Mr. Joel Stewart Dumaresq is a businessperson who founded Matrix Partners, Inc. and Pashleth Merchant Capital Corp. and who has been the head of 9 different companies. Presently, Mr. Dumaresq holds the position of Chairman & Chief Executive Officer of Organic Flower Investments.  Mr. Dumaresq brings 30 years’ experience in the financial sector, holding financial and investment management roles with RBC Dominion Securities, and was a managing director of Vancouver‐based private equity and merchant banking firm Matrix Partners Inc for 12 years. 


Mr. Dumaresq has extensive operational and senior management experience in the forestry, mining and energy spaces. He is presently an advisor to and an investor in, a range of Cannabis and CBD‐related businesses. Mr. Dumaresq received an undergraduate degree from the University of British Columbia and an undergraduate degree from Harvard University.


CANNABIS SECTOR – IN THE NEWS


In this section, the aim is to keep apprised of updates and advancements in the Cannabis sector and more importantly specific news items that are germane to Experion’s business and focus.  We have one such item to share this weekend, relating to the cannabis derivatives market


‘’Companies That Turn Plants into Oil and Derivative Products is Where Value will be Created in the Cannabis Industry’’


Please take a minute to select the link and listen to an interview with Paul Pedersen of Nextleaf Solutions.  https://www.bnnbloomberg.ca/investment-trends/video/companies-that-turn-plants-into-oil-and-derivative-products-is-where-value-will-be-created-in-the-cannabis-industry~1666842


How Is This Relevant to Experion, you ask?


On October 9, 2018, Experion announced that the Company had received an amended license from Health Canada allowing for the production and possession of cannabis oil (link to news release below).  This licensing achievement was a seminal first step for Experion to participate in the cannabis derivatives market


https://www.viridiumpacific.com/experion-receives-license-to-extract-and-product-cannabis-oil/


Mr. Jarrett Malnarick formerly CEO, now COO commented, ‘’We believe that a great deal of the next generation of cannabis products will be designed around cannabis extracts.  Experion has achieved another important milestone with the extraction amendment, which brings our company another step closer to our vision of building a leading, integrated cannabis company, operating across Canadian and International markets.”


CLOSING ARGUMENT


TODAY I WILL DO WHAT OTHERS WON'T – SO TOMORROW I CAN DO WHAT OTHERS CAN'T


Jerry Rice


The Case for Viridium/Experion:  Unique Advantage born out of thought leadership in the early phases to seek out and acquire a comprehensive set of licenses to supply all markets – today Experion is licensed for everything from R&D to distribution, for consumer markets and B2B


In essence, following the ‘’Jerry Rice Doctrine’’ Doing today what others won’t so that tomorrow we can do what others can’t… 


Viridium’s corporate growth strategy and vision are to build an industry-leading vertically integrated premium cannabis company through established supply chain and production methods, premium well-positioned consumer brands and through strategic partnerships for global operations.


When compared to peer groups, there is no doubt that Viridium is significantly undervalued on a market cap basis, revenue and on a share traded volume.  As a result, we believe that Viridium is therefore poised for significant stock price appreciation once Viridium starts trading in line with its peers.


Are We There Yet? – Trading in Line with Our Peers? – When will we get There?


Not quite – but we are on the road and are very much aware of the journey.  We have key investor awareness and marketing initiatives being set in place to garner a wider audience.  Management will continue to focus and execute its business plan and Investor Relations activities will communicate our accomplishments.  


Jay Garnett brought me on board for this sole purpose, commenting in the Company’s April 15th news release, “Viridium has made significant strides recently; our premium brands, quality operations and disciplined approach to growth will now be supported with a focused internal communications and outreach program. With Ms. Pottinger’s support and guidance, we will be able to more effectively connect Viridium’s story to the investment community while allowing our Senior Management team to focus on building our business.” 


Please Stay Tuned, and If you have not already done so, please join the Viridium portal on 8020 Connect http://connects.digital/Viridium8 and share the link – Let’s Not Keep VIR a Secret Any Longer!!!!


 

!
Thumb year end 2017

Darren Stewart replied to the press release Judy-Ann Pottinger  update in EXPERION HOLDINGS LTD. (TO BE CLOSED)

2 months

2 months

Darren Stewart posted a press release IN CASE YOU MISSED IT in EXPERION HOLDINGS LTD. (TO BE CLOSED)

Dear Investor  


IN CASE YOU MISSED IT


In a press release on Monday, May 13th – Viridium announced that the company had joined the 8020 Connect Investor Community and announced the Company’s AGM to be held on Friday, May 31, 2019


THE AGM


One of the matters to be considered at the AGM will be the election of Directors, each director of the Corporation is elected annually and holds office until the next AGM.  We have three new Directors being considered at the upcoming AGM – Michael Black, Michael Kohut, and Joel Dumaresq.  Having received several questions and request for additional information on these three new directors, we are providing a more detailed Bio for each of Michael Black, Michael Kohut, and Joel Dumaresq. 



Michael J. Black is the senior energy Partner in Fasken’s Calgary office. With significant experience leading large and complex M&A transactions, including several multi-billion-dollar M&A deals, Mr. Black is counsel to numerous domestic and international energy companies. Both clients and peers recognize him as a leading, results-oriented advisor.  Mr. Black has worked exclusively in the energy field, both in private practice and as in-house counsel, with a comprehensive focus on the upstream, midstream and the service sectors of the oil and gas business.  Mr. Black also negotiates and drafts a wide variety of domestic and international energy agreements, including joint operating, acquisition, joint venture, product marketing, and transportation, as well as farm-outs and production sharing contracts.  Having negotiated and closed transactions in over 20 countries, Mr. Black is an expert in providing legal and commercial advice in numerous jurisdictions. He was also the General Counsel of the state-owned oil and gas corporation in the State of Qatar. This combined with his extensive hands-on experience, both in private practice and as in-house counsel, allows him to be fully aligned with clients’ business objectives.


Mr. Black is a graduate of the Institute of Corporate Directors in Canada. Michael has been on the board of eight different companies, including roles as both Chairman of the Board and the Chairman of various committees. He is currently a director of two publicly traded companies.



Mr. Michael G. Kohut serves as the Senior Vice President and Chief Financial Officer at Canadian International Oil Corp. since February 2019. Mr. Kohut has been Chairman of Briko Energy Corp since April 11, 2019. Mr. Kohut was the President and Chief Executive Officer of Briko Energy Corp until April 11, 2019. He has been Chairman of the Board at Big Rock Brewery Inc. since November 9, 2017. He was the Vice President of Finance at Paramount Resources Ltd. from November 23, 2017, to April 2018. Mr. Kohut was the Chief Financial Officer of Paramount Resources (Trilogy Energy Corp) Ltd. since June 1, 2006, to October 2017. Mr. Kohut has over 15 years’ experience in financial management. Mr. Kohut served as President of Chinook Tyee Industry Limited (formerly, Global Railway Industries Ltd.) from January 1997 to October 3, 2005, and Chief Executive Officer until October 3, 2005. He served as Senior Tax Manager of KPMG in Calgary. He has been a Director of Big Rock Brewery Inc. since March 7, 2008, and Panterra Resource Corp. since May 22, 2014. He serves as an Independent Director at West Valley Energy Corp. He has been a Director of Great Prairie Energy Services Inc. since December 20, 2013. He has been a Director of Ikkuma Resources Corp. since May 22, 2014. He served as a Director at DevCorp Capital Inc. since February 4, 2011. He served as a Director of Chinook Tyee Industry Limited from January 1997 to October 3, 2005. He received a Chartered Accounting designation in 1992. He graduated from the University of Calgary with a Bachelor of Commerce in 1989.



Mr. Joel Stewart Dumaresq is a businessperson who founded Matrix Partners, Inc. and Pashleth Merchant Capital Corp. and who has been the head of 9 different companies. Presently, Mr. Dumaresq holds the position of Chairman & Chief Executive Officer of Organic Flower Investments.  Mr. Dumaresq brings 30 years’ experience in the financial sector, holding financial and investment management roles with RBC Dominion Securities, and was a managing director of Vancouver‐based private equity and merchant banking firm Matrix Partners Inc for 12 years. 


Mr. Dumaresq has extensive operational and senior management experience in the forestry, mining and energy spaces. He is presently an advisor to and an investor in, a range of Cannabis and CBD‐related businesses. Mr. Dumaresq received an undergraduate degree from the University of British Columbia and an undergraduate degree from Harvard University.


CANNABIS SECTOR – IN THE NEWS


In this section, the aim is to keep apprised of updates and advancements in the Cannabis sector and more importantly specific news items that are germane to Experion’s business and focus.  We have one such item to share this weekend, relating to the cannabis derivatives market


‘’Companies That Turn Plants into Oil and Derivative Products is Where Value will be Created in the Cannabis Industry’’


Please take a minute to select the link and listen to an interview with Paul Pedersen of Nextleaf Solutions.  https://www.bnnbloomberg.ca/investment-trends/video/companies-that-turn-plants-into-oil-and-derivative-products-is-where-value-will-be-created-in-the-cannabis-industry~1666842


How Is This Relevant to Experion, you ask?


On October 9, 2018, Experion announced that the Company had received an amended license from Health Canada allowing for the production and possession of cannabis oil (link to news release below).  This licensing achievement was a seminal first step for Experion to participate in the cannabis derivatives market


https://www.viridiumpacific.com/experion-receives-license-to-extract-and-product-cannabis-oil/


Mr. Jarrett Malnarick formerly CEO, now COO commented, ‘’We believe that a great deal of the next generation of cannabis products will be designed around cannabis extracts.  Experion has achieved another important milestone with the extraction amendment, which brings our company another step closer to our vision of building a leading, integrated cannabis company, operating across Canadian and International markets.”


CLOSING ARGUMENT


TODAY I WILL DO WHAT OTHERS WON'T – SO TOMORROW I CAN DO WHAT OTHERS CAN'T


Jerry Rice


The Case for Viridium/Experion:  Unique Advantage born out of thought leadership in the early phases to seek out and acquire a comprehensive set of licenses to supply all markets – today Experion is licensed for everything from R&D to distribution, for consumer markets and B2B


In essence, following the ‘’Jerry Rice Doctrine’’ Doing today what others won’t so that tomorrow we can do what others can’t… 


Viridium’s corporate growth strategy and vision are to build an industry-leading vertically integrated premium cannabis company through established supply chain and production methods, premium well-positioned consumer brands and through strategic partnerships for global operations.


When compared to peer groups, there is no doubt that Viridium is significantly undervalued on a market cap basis, revenue and on a share traded volume.  As a result, we believe that Viridium is therefore poised for significant stock price appreciation once Viridium starts trading in line with its peers.


Are We There Yet? – Trading in Line with Our Peers? – When will we get There?


Not quite – but we are on the road and are very much aware of the journey.  We have key investor awareness and marketing initiatives being set in place to garner a wider audience.  Management will continue to focus and execute its business plan and Investor Relations activities will communicate our accomplishments.  


Jay Garnett brought me on board for this sole purpose, commenting in the Company’s April 15th news release, “Viridium has made significant strides recently; our premium brands, quality operations and disciplined approach to growth will now be supported with a focused internal communications and outreach program. With Ms. Pottinger’s support and guidance, we will be able to more effectively connect Viridium’s story to the investment community while allowing our Senior Management team to focus on building our business.” 


Please Stay Tuned, and If you have not already done so, please join the Viridium portal on 8020 Connect http://connects.digital/Viridium8 and share the link – Let’s Not Keep VIR a Secret Any Longer!!!!


 

!

Judy-Ann Pottinger posted a press release IN CASE YOU MISSED IT in EXPERION HOLDINGS LTD. (TO BE CLOSED)

Dear Investor  


IN CASE YOU MISSED IT


In a press release on Monday, May 13th – Viridium announced that the company had joined the 8020 Connect Investor Community and announced the Company’s AGM to be held on Friday, May 31, 2019


THE AGM


One of the matters to be considered at the AGM will be the election of Directors, each director of the Corporation is elected annually and holds office until the next AGM.  We have three new Directors being considered at the upcoming AGM – Michael Black, Michael Kohut, and Joel Dumaresq.  Having received several questions and request for additional information on these three new directors, we are providing a more detailed Bio for each of Michael Black, Michael Kohut, and Joel Dumaresq. 



Michael J. Black is the senior energy Partner in Fasken’s Calgary office. With significant experience leading large and complex M&A transactions, including several multi-billion-dollar M&A deals, Mr. Black is counsel to numerous domestic and international energy companies. Both clients and peers recognize him as a leading, results-oriented advisor.  Mr. Black has worked exclusively in the energy field, both in private practice and as in-house counsel, with a comprehensive focus on the upstream, midstream and the service sectors of the oil and gas business.  Mr. Black also negotiates and drafts a wide variety of domestic and international energy agreements, including joint operating, acquisition, joint venture, product marketing, and transportation, as well as farm-outs and production sharing contracts.  Having negotiated and closed transactions in over 20 countries, Mr. Black is an expert in providing legal and commercial advice in numerous jurisdictions. He was also the General Counsel of the state-owned oil and gas corporation in the State of Qatar. This combined with his extensive hands-on experience, both in private practice and as in-house counsel, allows him to be fully aligned with clients’ business objectives.


Mr. Black is a graduate of the Institute of Corporate Directors in Canada. Michael has been on the board of eight different companies, including roles as both Chairman of the Board and the Chairman of various committees. He is currently a director of two publicly traded companies.



Mr. Michael G. Kohut serves as the Senior Vice President and Chief Financial Officer at Canadian International Oil Corp. since February 2019. Mr. Kohut has been Chairman of Briko Energy Corp since April 11, 2019. Mr. Kohut was the President and Chief Executive Officer of Briko Energy Corp until April 11, 2019. He has been Chairman of the Board at Big Rock Brewery Inc. since November 9, 2017. He was the Vice President of Finance at Paramount Resources Ltd. from November 23, 2017, to April 2018. Mr. Kohut was the Chief Financial Officer of Paramount Resources (Trilogy Energy Corp) Ltd. since June 1, 2006, to October 2017. Mr. Kohut has over 15 years’ experience in financial management. Mr. Kohut served as President of Chinook Tyee Industry Limited (formerly, Global Railway Industries Ltd.) from January 1997 to October 3, 2005, and Chief Executive Officer until October 3, 2005. He served as Senior Tax Manager of KPMG in Calgary. He has been a Director of Big Rock Brewery Inc. since March 7, 2008, and Panterra Resource Corp. since May 22, 2014. He serves as an Independent Director at West Valley Energy Corp. He has been a Director of Great Prairie Energy Services Inc. since December 20, 2013. He has been a Director of Ikkuma Resources Corp. since May 22, 2014. He served as a Director at DevCorp Capital Inc. since February 4, 2011. He served as a Director of Chinook Tyee Industry Limited from January 1997 to October 3, 2005. He received a Chartered Accounting designation in 1992. He graduated from the University of Calgary with a Bachelor of Commerce in 1989.



Mr. Joel Stewart Dumaresq is a businessperson who founded Matrix Partners, Inc. and Pashleth Merchant Capital Corp. and who has been the head of 9 different companies. Presently, Mr. Dumaresq holds the position of Chairman & Chief Executive Officer of Organic Flower Investments.  Mr. Dumaresq brings 30 years’ experience in the financial sector, holding financial and investment management roles with RBC Dominion Securities, and was a managing director of Vancouver‐based private equity and merchant banking firm Matrix Partners Inc for 12 years. 


Mr. Dumaresq has extensive operational and senior management experience in the forestry, mining and energy spaces. He is presently an advisor to and an investor in, a range of Cannabis and CBD‐related businesses. Mr. Dumaresq received an undergraduate degree from the University of British Columbia and an undergraduate degree from Harvard University.


CANNABIS SECTOR – IN THE NEWS


In this section, the aim is to keep apprised of updates and advancements in the Cannabis sector and more importantly specific news items that are germane to Experion’s business and focus.  We have one such item to share this weekend, relating to the cannabis derivatives market


‘’Companies That Turn Plants into Oil and Derivative Products is Where Value will be Created in the Cannabis Industry’’


Please take a minute to select the link and listen to an interview with Paul Pedersen of Nextleaf Solutions.  https://www.bnnbloomberg.ca/investment-trends/video/companies-that-turn-plants-into-oil-and-derivative-products-is-where-value-will-be-created-in-the-cannabis-industry~1666842


How Is This Relevant to Experion, you ask?


On October 9, 2018, Experion announced that the Company had received an amended license from Health Canada allowing for the production and possession of cannabis oil (link to news release below).  This licensing achievement was a seminal first step for Experion to participate in the cannabis derivatives market


https://www.viridiumpacific.com/experion-receives-license-to-extract-and-product-cannabis-oil/


Mr. Jarrett Malnarick formerly CEO, now COO commented, ‘’We believe that a great deal of the next generation of cannabis products will be designed around cannabis extracts.  Experion has achieved another important milestone with the extraction amendment, which brings our company another step closer to our vision of building a leading, integrated cannabis company, operating across Canadian and International markets.”


CLOSING ARGUMENT


TODAY I WILL DO WHAT OTHERS WON'T – SO TOMORROW I CAN DO WHAT OTHERS CAN'T


Jerry Rice


The Case for Viridium/Experion:  Unique Advantage born out of thought leadership in the early phases to seek out and acquire a comprehensive set of licenses to supply all markets – today Experion is licensed for everything from R&D to distribution, for consumer markets and B2B


In essence, following the ‘’Jerry Rice Doctrine’’ Doing today what others won’t so that tomorrow we can do what others can’t… 


Viridium’s corporate growth strategy and vision are to build an industry-leading vertically integrated premium cannabis company through established supply chain and production methods, premium well-positioned consumer brands and through strategic partnerships for global operations.


When compared to peer groups, there is no doubt that Viridium is significantly undervalued on a market cap basis, revenue and on a share traded volume.  As a result, we believe that Viridium is therefore poised for significant stock price appreciation once Viridium starts trading in line with its peers.


Are We There Yet? – Trading in Line with Our Peers? – When will we get There?


Not quite – but we are on the road and are very much aware of the journey.  We have key investor awareness and marketing initiatives being set in place to garner a wider audience.  Management will continue to focus and execute its business plan and Investor Relations activities will communicate our accomplishments.  


Jay Garnett brought me on board for this sole purpose, commenting in the Company’s April 15th news release, “Viridium has made significant strides recently; our premium brands, quality operations and disciplined approach to growth will now be supported with a focused internal communications and outreach program. With Ms. Pottinger’s support and guidance, we will be able to more effectively connect Viridium’s story to the investment community while allowing our Senior Management team to focus on building our business.” 


Please Stay Tuned, and If you have not already done so, please join the Viridium portal on 8020 Connect http://connects.digital/Viridium8 and share the link – Let’s Not Keep VIR a Secret Any Longer!!!!


 

!